isoxazoles has been researched along with nornicotine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arneric, SP; Brioni, JD; Buckley, MJ; Carrera, GM; Decker, MW; Garvey, DS; Holladay, MW; Sullivan, JP; Wasicak, JT; Williams, M | 1 |
| Barr, JD; Bevins, RA; Murray, JE; Reichel, CM | 1 |
2 other study(ies) available for isoxazoles and nornicotine
| Article | Year |
|---|---|
Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities.
Topics: Alkaloids; Animals; Anti-Anxiety Agents; Azocines; Binding Sites; Brain; Bungarotoxins; Cognition; Isoxazoles; Mice; Molecular Structure; Motor Activity; Nicotine; Quinolizines; Rats; Receptors, Cholinergic; Receptors, Nicotinic; Stereoisomerism | 1994 |
Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine.
Topics: Animals; Benzazepines; Conditioning, Classical; Discrimination, Psychological; Extinction, Psychological; Generalization, Psychological; Isoxazoles; Ligands; Male; Nicotine; Nicotinic Agonists; Pyrrolidines; Quinoxalines; Rats; Rats, Sprague-Dawley; Varenicline | 2010 |